These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 497556)

  • 21. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supersensitivity of cerebral dopamine receptors during on-going chronic (six months) administration of trifluoperazine to rats [proceedings].
    Clow A; Jenner P; Marsden CD
    Br J Pharmacol; 1978 Nov; 64(3):414P. PubMed ID: 719266
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sulpiride (stereoisomers, racemic) and dopamine: actions and interactions on renal excretion of hydro-saline].
    Agnoli GC; Andreone P; Cacciari M; Garutti C; Ikonomu E; Lenzi P
    Boll Soc Ital Biol Sper; 1984 Jan; 60(1):181-6. PubMed ID: 6704245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacology of sulpiride--a dopamine receptor antagonist.
    O'Connor SE; Brown RA
    Gen Pharmacol; 1982; 13(3):185-93. PubMed ID: 7047291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay.
    Mizuchi A; Kitagawa N; Miyachi Y
    Psychopharmacology (Berl); 1983; 81(3):195-8. PubMed ID: 6417707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of enantiomers of sultopride in a human, rats and rabbits.
    Kamizono A; Inotsume N; Fukushima S; Nakano M
    Biol Pharm Bull; 1993 Nov; 16(11):1121-3. PubMed ID: 7906175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible mechanism of antidepressant effect of L-sulpiride.
    Serra G; Forgione A; D'Aquila PS; Collu M; Fratta W; Gessa GL
    Clin Neuropharmacol; 1990; 13 Suppl 1():S76-83. PubMed ID: 2199037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of psychiatric emergencies with a new neuroleptic drug: sultopride].
    Planche R
    Sem Hop Ther; 1976 Apr; 52(4):261-2. PubMed ID: 948771
    [No Abstract]   [Full Text] [Related]  

  • 29. [Preliminary clinical impressions following the use of sultopride in the treatment of manic agitation states].
    Genevieve JM; Couriol A
    Sem Hop Ther; 1976; 52(5-6):329-30. PubMed ID: 968498
    [No Abstract]   [Full Text] [Related]  

  • 30. Copper-Catalyzed Alkene Diamination: Synthesis of Chiral 2-Aminomethyl Indolines and Pyrrolidines.
    Turnpenny BW; Chemler SR
    Chem Sci; 2014 May; 5(5):1786-1793. PubMed ID: 24932404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3[H]-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs.
    Csernansky JG; Csernansky CA; Hollister LE
    Experientia; 1985 Nov; 41(11):1419-21. PubMed ID: 4065296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain.
    Moriuchi K; Imazu Y; Yoneda H
    Neurochem Res; 1995 Jan; 20(1):95-9. PubMed ID: 7739765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
    Hasan F; Leonard BE
    Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
    [No Abstract]   [Full Text] [Related]  

  • 34. [Stereoisomers of sulpiride and dopamine: interaction on kidney function in humans].
    Agnoli GC; Cacciari M; Cariani A; Garutti C; Ikonomu E; Lenzi P
    Cardiologia; 1983 Jun; 28(6):489-508. PubMed ID: 6687180
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.
    Spano PF; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1978; 19():155-65. PubMed ID: 358777
    [No Abstract]   [Full Text] [Related]  

  • 36. Stereoselective blockade of cerebral dopamine receptors by sulpiride and sultopride [proceedings].
    Clow A; Jenner P; Marsden CD; Reavill C; Theodorou A
    Br J Pharmacol; 1979 Nov; 67(3):433P. PubMed ID: 497556
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum.
    Garau L; Govoni S; Stefanini E; Trabucchi M; Spano PF
    Life Sci; 1978 Oct; 23(17-18):1745-50. PubMed ID: 723447
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of the (+)-and (-)-enantiomers of sulpiride on ADTN-induced hyperactivity in the rat [proceedings].
    Andrews CD; Woodruff GN
    Br J Pharmacol; 1978 Nov; 64(3):434P. PubMed ID: 719284
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles.
    Marsden CA; Curzon G
    Neuropharmacology; 1977; 16(7-8):489-94. PubMed ID: 144245
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.